9. LightPath Technologies (LPTH)
Company Profile: LightPath Technologies produces optical components and technologies that serve the medical, industrial, defense and communications industries.Altman Z-score: -35.47 Current Share Price: $1.66 (June 7) 2011 Return: -8% Current Ratio: 2.90, indicating that LightPath would be able to meet its short-term liabilities with its current assets.
8. Cell Therapeutics (CTICD) Company Profile: Cell Therapeutics is a biopharmaceutical company with a focus on oncology. Last month, TheStreet's Adam Feuerstein reported that the Food and Drug Administration had again rejected pixantrone, which is Cell Therapeutics' treatment for non-Hodgkin's lymphoma. Altman Z-score: -37.19 Current Share Price: $2.19 (June 7) 2011 Return: The stock is unchanged this year. Current Ratio: 1.20, indicating that Cell Therapeutics should be able to meet its short-term liabilities with its current assets.